References
- Strandness DE Jr. The research initiative meeting and the National Institutes of Health. J. Vasc. Surg.23, 1058–1068 (1996).
- Pearce WH, Mannick JA, Clowes AW, Yao JS. Twentieth anniversary of American Vascular Association/Lifeline Foundation: a celebration. J. Vasc. Surg.47, 1351–1355 (2008).
- Conte MS, Bandyk DF, Clowes AW et al. PREVENT III Investigators: results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J. Vasc. Surg.43, 742–751 (2006).
- Alexander JH, Hafley G, Harrington RA et al.; PREVENT IV investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery. PREVENT IV: a randomized controlled trial. JAMA294, 2446–2454 (2005).
Website
- Thrombosis, Vascular Biology and Surgery – Steven Lentz www.youtube.com/watch?v=6TfuJ8-zlBU (Accessed 11 May 2011)